KR920021144A - 역류성 식도염을 치료하기위한 니자티딘의 용도 - Google Patents

역류성 식도염을 치료하기위한 니자티딘의 용도 Download PDF

Info

Publication number
KR920021144A
KR920021144A KR1019920008916A KR920008916A KR920021144A KR 920021144 A KR920021144 A KR 920021144A KR 1019920008916 A KR1019920008916 A KR 1019920008916A KR 920008916 A KR920008916 A KR 920008916A KR 920021144 A KR920021144 A KR 920021144A
Authority
KR
South Korea
Prior art keywords
nizatidine
reflux esophagitis
treat reflux
ulcers
dosage regimen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019920008916A
Other languages
English (en)
Korean (ko)
Inventor
루이스 클라우드 미쉘
Original Assignee
리로이 휘테커
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리로이 휘테커, 일라이 릴리 앤드 캄파니 filed Critical 리로이 휘테커
Publication of KR920021144A publication Critical patent/KR920021144A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019920008916A 1991-05-28 1992-05-26 역류성 식도염을 치료하기위한 니자티딘의 용도 Withdrawn KR920021144A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70614591A 1991-05-28 1991-05-28
US706,145 1991-05-28

Publications (1)

Publication Number Publication Date
KR920021144A true KR920021144A (ko) 1992-12-18

Family

ID=24836392

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920008916A Withdrawn KR920021144A (ko) 1991-05-28 1992-05-26 역류성 식도염을 치료하기위한 니자티딘의 용도

Country Status (10)

Country Link
EP (1) EP0516345A1 (enExample)
JP (1) JPH05148142A (enExample)
KR (1) KR920021144A (enExample)
AU (1) AU1721892A (enExample)
CA (1) CA2069162A1 (enExample)
HU (1) HU9201751D0 (enExample)
MX (1) MX9202507A (enExample)
NO (1) NO922019L (enExample)
TW (1) TW202387B (enExample)
ZA (1) ZA923711B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
WO2006047493A2 (en) 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
DK3354276T3 (da) * 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them

Also Published As

Publication number Publication date
NO922019L (no) 1992-11-30
CA2069162A1 (en) 1992-11-29
JPH05148142A (ja) 1993-06-15
NO922019D0 (no) 1992-05-22
AU1721892A (en) 1992-12-03
TW202387B (enExample) 1993-03-21
EP0516345A1 (en) 1992-12-02
MX9202507A (es) 1992-11-01
ZA923711B (en) 1993-11-22
HU9201751D0 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
KR920019347A (ko) 당뇨병의 치료방법
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
ES2052495T3 (es) Terapia de fluidos con aniones l-lactato y/o piruvato.
KR890004709A (ko) 항원충제로서의 아지트로마이신 및 이의 유도체
KR870005637A (ko) 약물 데포
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
KR920000315A (ko) 모다피닐의 용도
SE8803486L (sv) Dosform foer behandling av kardiovaskulaera sjukdomar
KR900701261A (ko) 비만증 치료방법
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
KR950007848A (ko) (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
KR890000097A (ko) 항레트로비루스 작용을 갖는 당단백질 처리 억제제
KR910018381A (ko) 개선된 에르골린-8-카복스아미드
KR910009267A (ko) 우울증의 치료방법
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
KR920017668A (ko) 암 전이 억제 또는 예방 방법 및 이를 위한 제제
KR940701249A (ko) 진통제
IT1224250B (it) Associzione del depiprazolo con la morfina
FI945446A0 (fi) Kotiinin käyttö tupakan vieroitusoireyhtymän lievittämiseksi
KR910016327A (ko) 호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
KR880004810A (ko) 소화성 궤양 치료제
KR910700263A (ko) 시클로리노펩티드를 포함하는 의약
KR920019369A (ko) 위장병에 유용한 제약학적 복합 성분물

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19920526

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid